UTHR insider transaction filings
UNITED THERAPEUTICS Corp — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-21. Screen UTHR transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-21 | 4 | MAHON PAUL A — EVP & GENERAL COUNSEL | Option exercise (M): 2,690 @ $146.03 · Option exercise (M): 5,610 @ $146.03 · Sale (S): 2,690 @ $524.15 · Sale (S): 502 @ $520.03 · Sale (S): 1,819 @ $521.04 · Sale (S): 787 @ $522.00 · +7 more | EDGAR |
| 2026-08-21 | 4 | ROTHBLATT MARTINE A — Chairperson & CEO, Director | Option exercise (M): 9,500 @ $135.42 · Sale (S): 976 @ $518.45 · Sale (S): 1,504 @ $519.51 · Sale (S): 2,357 @ $520.46 · Sale (S): 2,470 @ $521.39 · Sale (S): 960 @ $522.37 · +4 more | EDGAR |
| 2026-08-20 | 4 | ROTHBLATT MARTINE A — Chairperson & CEO, Director | Option exercise (M): 9,500 @ $135.42 · Sale (S): 240 @ $522.49 · Sale (S): 1,264 @ $523.65 · Sale (S): 441 @ $524.51 · Sale (S): 895 @ $525.60 · Sale (S): 2,105 @ $526.76 · +8 more | EDGAR |
| 2026-08-19 | 4 | ROTHBLATT MARTINE A — Chairperson & CEO, Director | Option exercise (M): 9,500 @ $135.42 · Sale (S): 239 @ $509.48 · Sale (S): 231 @ $510.47 · Sale (S): 170 @ $511.59 · Sale (S): 439 @ $513.06 · Sale (S): 1,264 @ $514.18 · +6 more | EDGAR |
| 2026-08-18 | 4 | ROTHBLATT MARTINE A — Chairperson & CEO, Director | Option exercise (M): 9,500 @ $135.42 · Sale (S): 213 @ $501.06 · Sale (S): 427 @ $502.18 · Sale (S): 120 @ $504.21 · Sale (S): 1,238 @ $505.36 · Sale (S): 2,521 @ $506.35 · +3 more | EDGAR |
| 2026-08-17 | 4 | ROTHBLATT MARTINE A — Chairperson & CEO, Director | Option exercise (M): 9,500 @ $135.42 · Sale (S): 320 @ $495.02 · Sale (S): 414 @ $495.96 · Sale (S): 537 @ $497.22 · Sale (S): 2,130 @ $498.39 · Sale (S): 3,630 @ $499.30 · +3 more | EDGAR |
| 2026-08-14 | 4 | ROTHBLATT MARTINE A — Chairperson & CEO, Director | Option exercise (M): 9,500 @ $135.42 · Sale (S): 1,253 @ $500.08 · Sale (S): 1,328 @ $500.93 · Sale (S): 1,519 @ $501.88 · Sale (S): 440 @ $502.93 · Sale (S): 160 @ $503.83 · +8 more | EDGAR |
| 2026-08-13 | 4 | ROTHBLATT MARTINE A — Chairperson & CEO, Director | Option exercise (M): 9,500 @ $135.42 · Sale (S): 40 @ $507.08 · Sale (S): 440 @ $508.86 · Sale (S): 280 @ $509.61 · Sale (S): 1,152 @ $511.12 · Sale (S): 542 @ $511.75 · +10 more | EDGAR |
| 2026-08-12 | 4 | ROTHBLATT MARTINE A — Chairperson & CEO, Director | Option exercise (M): 9,500 @ $135.42 · Sale (S): 475 @ $513.37 · Sale (S): 1,214 @ $514.52 · Sale (S): 360 @ $515.52 · Sale (S): 520 @ $516.91 · Sale (S): 120 @ $517.57 · +12 more | EDGAR |
| 2026-08-11 | 4 | ROTHBLATT MARTINE A — Chairperson & CEO, Director | Option exercise (M): 9,500 @ $135.42 · Sale (S): 578 @ $523.95 · Sale (S): 582 @ $524.86 · Sale (S): 120 @ $525.73 · Sale (S): 722 @ $527.38 · Sale (S): 731 @ $528.40 · +10 more | EDGAR |
| 2026-08-10 | 4 | ROTHBLATT MARTINE A — Chairperson & CEO, Director | Option exercise (M): 9,500 @ $135.42 · Sale (S): 357 @ $525.29 · Sale (S): 1,112 @ $526.15 · Sale (S): 411 @ $526.82 · Sale (S): 240 @ $527.72 · Sale (S): 709 @ $529.14 · +11 more | EDGAR |
| 2026-08-07 | 4 | ROTHBLATT MARTINE A — Chairperson & CEO, Director | Option exercise (M): 9,500 @ $135.42 · Sale (S): 80 @ $512.50 · Sale (S): 625 @ $514.92 · Sale (S): 263 @ $516.21 · Sale (S): 120 @ $516.73 · Sale (S): 80 @ $517.83 · +14 more | EDGAR |
| 2026-08-06 | 4 | ROTHBLATT MARTINE A — Chairperson & CEO, Director | Option exercise (M): 9,500 @ $135.42 · Sale (S): 200 @ $502.29 · Sale (S): 80 @ $504.31 · Sale (S): 160 @ $507.24 · Sale (S): 160 @ $510.28 · Sale (S): 80 @ $511.07 · +12 more | EDGAR |
| 2026-08-06 | 4 | MAHON PAUL A — EVP & GENERAL COUNSEL | Option exercise (M): 8,300 @ $146.03 · Sale (S): 760 @ $512.92 · Sale (S): 1,795 @ $514.82 · Sale (S): 1,360 @ $515.93 · Sale (S): 1,617 @ $516.93 · Sale (S): 780 @ $517.94 · +4 more | EDGAR |
| 2026-08-05 | 4 | ROTHBLATT MARTINE A — Chairperson & CEO, Director | Option exercise (M): 9,500 @ $135.42 · Sale (S): 178 @ $512.49 · Sale (S): 182 @ $513.39 · Sale (S): 675 @ $514.43 · Sale (S): 605 @ $515.50 · Sale (S): 2,456 @ $516.59 · +5 more | EDGAR |
| 2026-08-04 | 4 | ROTHBLATT MARTINE A — Chairperson & CEO, Director | Option exercise (M): 9,500 @ $135.42 · Sale (S): 1,667 @ $514.83 · Sale (S): 4,218 @ $515.73 · Sale (S): 2,075 @ $516.49 · Sale (S): 1,220 @ $517.49 · Sale (S): 320 @ $518.61 · +1 more | EDGAR |
| 2026-08-03 | 4 | ROTHBLATT MARTINE A — Chairperson & CEO, Director | Option exercise (M): 9,500 @ $135.42 · Sale (S): 365 @ $514.82 · Sale (S): 857 @ $515.84 · Sale (S): 1,133 @ $516.94 · Sale (S): 1,215 @ $518.00 · Sale (S): 1,266 @ $519.06 · +5 more | EDGAR |
| 2026-07-31 | 4 | ROTHBLATT MARTINE A — Chairperson & CEO, Director | Option exercise (M): 9,500 @ $135.42 · Sale (S): 644 @ $523.04 · Sale (S): 1,486 @ $523.87 · Sale (S): 4,846 @ $524.88 · Sale (S): 2,084 @ $525.80 · Sale (S): 400 @ $526.92 · +2 more | EDGAR |
| 2026-07-30 | 4 | ROTHBLATT MARTINE A — Chairperson & CEO, Director | Option exercise (M): 9,500 @ $135.42 · Sale (S): 798 @ $518.25 · Sale (S): 1,112 @ $519.29 · Sale (S): 900 @ $520.40 · Sale (S): 1,270 @ $521.32 · Sale (S): 880 @ $522.51 · +4 more | EDGAR |
| 2026-07-28 | 4 | ROTHBLATT MARTINE A — Chairperson & CEO, Director | Option exercise (M): 9,500 @ $135.42 · Sale (S): 1,367 @ $523.15 · Sale (S): 1,074 @ $524.04 · Sale (S): 876 @ $525.02 · Sale (S): 1,473 @ $526.34 · Sale (S): 1,369 @ $527.16 · +6 more | EDGAR |
| 2026-07-27 | 4 | ROTHBLATT MARTINE A — Chairperson & CEO, Director | Option exercise (M): 9,500 @ $135.42 · Sale (S): 680 @ $525.81 · Sale (S): 890 @ $527.14 · Sale (S): 650 @ $528.51 · Sale (S): 1,797 @ $529.75 · Sale (S): 1,121 @ $530.49 · +5 more | EDGAR |
| 2026-07-27 | 4 | ROTHBLATT MARTINE A — Chairperson & CEO, Director | Option exercise (M): 9,500 @ $135.42 · Sale (S): 820 @ $528.72 · Sale (S): 2,285 @ $530.45 · Sale (S): 1,115 @ $531.10 · Sale (S): 2,719 @ $532.27 · Sale (S): 1,818 @ $533.20 · +3 more | EDGAR |
| 2026-07-24 | 4 | ROTHBLATT MARTINE A — Chairperson & CEO, Director | Option exercise (M): 9,500 @ $135.42 · Sale (S): 249 @ $522.87 · Sale (S): 339 @ $523.72 · Sale (S): 171 @ $524.86 · Sale (S): 387 @ $525.83 · Sale (S): 552 @ $526.88 · +6 more | EDGAR |
| 2026-07-23 | 4 | Tracey Kevin — Director | Grant/award (A): 760 (derivative) @ $0 | EDGAR |
| 2026-07-23 | 4 | MALCOLM JAN — Director | Grant/award (A): 380 (derivative) @ $0 · Grant/award (A): 1,190 (derivative) @ $0 | EDGAR |
| 2026-07-23 | 4 | MAXWELL LINDA — Director | Grant/award (A): 380 (derivative) @ $0 · Grant/award (A): 1,190 (derivative) @ $0 | EDGAR |
| 2026-07-23 | 4 | Mesa Nilda — Director | Grant/award (A): 380 (derivative) @ $0 · Grant/award (A): 1,190 (derivative) @ $0 | EDGAR |
| 2026-07-23 | 4 | Olian Judy D. — Director | Grant/award (A): 760 (derivative) @ $0 | EDGAR |
| 2026-07-23 | 4 | Giltner Richard — Director | Grant/award (A): 760 (derivative) @ $0 | EDGAR |
| 2026-07-23 | 4 | Thompson Tommy G — Director | Grant/award (A): 380 (derivative) @ $0 · Grant/award (A): 1,190 (derivative) @ $0 | EDGAR |
| 2026-07-23 | 4 | CAUSEY CHRISTOPHER — Director | Grant/award (A): 2,380 (derivative) @ $0 | EDGAR |
| 2026-07-23 | 4 | PATUSKY CHRISTOPHER — Director | Grant/award (A): 2,380 (derivative) @ $0 | EDGAR |
| 2026-07-23 | 4 | DZAU VICTOR J — Director | Grant/award (A): 730 (derivative) @ $0 · Grant/award (A): 2,300 (derivative) @ $0 | EDGAR |
| 2026-07-23 | 4 | SULLIVAN LOUIS W — Director | Grant/award (A): 2,380 (derivative) @ $0 | EDGAR |
| 2026-07-23 | 4 | KURZWEIL RAY — Director | Grant/award (A): 380 (derivative) @ $0 · Grant/award (A): 1,190 (derivative) @ $0 | EDGAR |
| 2026-07-23 | 4 | ROTHBLATT MARTINE A — Chairperson & CEO, Director | Option exercise (M): 9,500 @ $135.42 · Sale (S): 120 @ $524.27 · Sale (S): 485 @ $526.04 · Sale (S): 2,610 @ $526.84 · Sale (S): 1,211 @ $527.82 · Sale (S): 874 @ $528.91 · +10 more | EDGAR |
| 2026-07-22 | 4 | ROTHBLATT MARTINE A — Chairperson & CEO, Director | Option exercise (M): 9,500 @ $135.42 · Sale (S): 120 @ $524.37 · Sale (S): 160 @ $526.24 · Sale (S): 240 @ $527.46 · Sale (S): 509 @ $529.55 · Sale (S): 1,926 @ $530.50 · +7 more | EDGAR |
| 2026-07-21 | 4 | ROTHBLATT MARTINE A — Chairperson & CEO, Director | Option exercise (M): 9,500 @ $135.42 · Sale (S): 1,831 @ $529.19 · Sale (S): 960 @ $529.85 · Sale (S): 1,660 @ $531.08 · Sale (S): 1,874 @ $532.07 · Sale (S): 1,686 @ $533.03 · +4 more | EDGAR |
| 2026-07-20 | 4 | ROTHBLATT MARTINE A — Chairperson & CEO, Director | Option exercise (M): 9,500 @ $135.42 · Sale (S): 240 @ $528.91 · Sale (S): 240 @ $530.83 · Sale (S): 720 @ $534.57 · Sale (S): 2,350 @ $535.53 · Sale (S): 2,110 @ $536.36 · +7 more | EDGAR |
| 2026-07-17 | 4 | ROTHBLATT MARTINE A — Chairperson & CEO, Director | Option exercise (M): 9,500 @ $135.42 · Sale (S): 80 @ $527.31 · Sale (S): 1,400 @ $528.42 · Sale (S): 3,057 @ $529.46 · Sale (S): 1,924 @ $530.14 · Sale (S): 520 @ $532.14 · +6 more | EDGAR |
| 2026-07-16 | 4 | MAHON PAUL A — EVP & GENERAL COUNSEL | Option exercise (M): 8,300 @ $146.03 · Sale (S): 600 @ $527.60 · Sale (S): 120 @ $529.81 · Sale (S): 861 @ $531.97 · Sale (S): 800 @ $532.94 · Sale (S): 3,279 @ $534.21 · +4 more | EDGAR |
| 2026-07-16 | 4 | ROTHBLATT MARTINE A — Chairperson & CEO, Director | Option exercise (M): 1,718 @ $135.42 · Sale (S): 80 @ $521.82 · Sale (S): 120 @ $523.97 · Sale (S): 80 @ $525.42 · Sale (S): 40 @ $527.55 · Sale (S): 120 @ $529.66 · +19 more | EDGAR |
| 2026-07-15 | 4 | ROTHBLATT MARTINE A — Chairperson & CEO, Director | Option exercise (M): 9,500 @ $135.42 · Sale (S): 840 @ $524.15 · Sale (S): 1,468 @ $525.16 · Sale (S): 3,492 @ $526.13 · Sale (S): 1,220 @ $527.06 · Sale (S): 660 @ $528.13 · +5 more | EDGAR |
| 2026-07-14 | 4 | ROTHBLATT MARTINE A — Chairperson & CEO, Director | Option exercise (M): 9,500 @ $135.42 · Sale (S): 1,020 @ $533.70 · Sale (S): 2,272 @ $534.63 · Sale (S): 2,191 @ $535.47 · Sale (S): 2,223 @ $536.52 · Sale (S): 665 @ $537.66 · +5 more | EDGAR |
| 2026-07-13 | 4 | Mesa Nilda — Director | Option exercise (M): 650 @ $0 · Option exercise (M): 650 (derivative) @ $0 | EDGAR |
| 2026-07-13 | 4 | Olian Judy D. — Director | Option exercise (M): 1,310 @ $0 · Option exercise (M): 1,310 (derivative) | EDGAR |
| 2026-07-13 | 4 | Giltner Richard — Director | Option exercise (M): 1,310 @ $0 · Option exercise (M): 1,310 (derivative) @ $0 | EDGAR |
| 2026-07-13 | 4 | PATUSKY CHRISTOPHER — Director | Option exercise (M): 650 @ $0 · Option exercise (M): 650 (derivative) @ $0 | EDGAR |
| 2026-07-13 | 4 | SULLIVAN LOUIS W — Director | Option exercise (M): 650 @ $0 · Option exercise (M): 650 (derivative) @ $0 | EDGAR |
| 2026-07-13 | 4 | KURZWEIL RAY — Director | Option exercise (M): 650 @ $0 · Option exercise (M): 650 (derivative) @ $0 | EDGAR |
Recent 8-K events — UNITED THERAPEUTICS Corp
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-05 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-23 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-29 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-30 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-09 | 8-K | 1.01 — Entry into a Material Definitive Agreement 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-02 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-02-25 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-22 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-29 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=UTHR returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →